Trial intelligence / Profile preview

Comparison of melatonin and zinc for sleep disorders in cirrhotic patients

IRCT20121021011192N18Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of melatonin and zinc in Cirrhosis and sleep disorder (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Optimization of sleep disorder. Started Aug 2024; status: completed.

02

Drugs

melatoninzinc
03

Conditions

Cirrhosissleep disorder

Beyond the preview

Go deeper on IRCT20121021011192N18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20121021011192N18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call